Skip to content

Home
Stock Ideas
About Newsheater
- Authors
- Contact Us
Privacy Policy

Menu

Home
Stock Ideas
About Newsheater
- Authors
- Contact Us
Privacy Policy

Tag: NASDAQ:AKTX

Trending

Akari Therapeutics Plc ADR (AKTX) Stock: What the Analysts are Saying

The stock has a 36-month beta value of 0.97. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 2 as

NewsHeater is specialized on the investments in tech sphere. Its specialists are interested in stocks that have been undervalued by different reasons. They are trying to find them, count their potential and bring them to their clients.

Navigation

About
Authors
Contact US
Disclaimer
Privacy Policy

Companies
Morning Brief
Stocks Ideas
Equity Research
Analyst insight

Newsletter

Get the hottest stocks to trade every day before the market opens 100% free.

© 2024, Fueled by Smart TechOne

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.